THE WHO MAKES COPYRIGHT WEIGHT LOSS DIARIES

U.S. pharma giant copyright scrapped two experimental weight loss supplements last year—a when-daily tablet, lotiglipron, due to elevated liver enzymes in addition to a 2 times-each day tablet, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has said the company is determined to “play and acquire” while in the obesity Ar